Wenzel, Joerg http://orcid.org/0000-0002-4744-5993
Article History
Accepted: 8 July 2019
First Online: 9 August 2019
Competing interests
: J.W. declares that he has received financial support from GSK (for clinical studies, investigator-initiated trials and advisory board fees), Incyte (for investigator-initiated trials), Spirig (for an investigator-initiated trial), Medac (for advisory board fees), Actelion (for advisory board fees), Celgene (for advisory board fees), Biogen (for advisory board fees), Roche (for advisory board fees and clinical studies), Leo (for advisory board fees and clinical studies), Merck Serono (for clinical studies) and ArrayBio (for clinical studies).